Open AccessDiabetes mellitus and cancer: a system of insulin-like growth factors
Author(s) -
Elena M. Frantsiyants,
Ekaterina I. Surikova,
Irina V. Kaplieva,
В. А. Бандовкина,
Yulia A. Pogorelova,
Elena A. Sheiko,
M.I. Morozova,
И. М. Котиева
Publication year - 2021
Publication title -
problemy èndokrinologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 5
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl12741
Subject(s) - hyperinsulinemia , diabetes mellitus , carcinogenesis , context (archaeology) , insulin , insulin like growth factor 1 receptor , cancer , medicine , insulin receptor , bioinformatics , biology , endocrinology , receptor , cancer research , growth factor , insulin resistance , paleontology
Diabetes mellitus and malignant tumors are among the most common and complex diseases. Epidemiological studies have shown a strong relationship between these pathologies. The causality of this relationship has not yet been unambiguously established, but a number of probable biological mechanisms have been proposed to explain it through the effects of hyperglycemia, hyperinsulinemia on the process of oncogenesis. An important role in this is played by the axis of insulin-like growth factors, their receptors and binding proteins (IGF / IGFR / IGFBP). The review provides data on the structural elements of the insulin / IGF / IGFR / IGFBP signaling axis and their internal relationships in diabetes mellitus and in the development of malignant tumors. Significant changes in the axis that occur during the formation of the diabetic environment prepare the background, which, under certain conditions, can lead to the stimulation or inhibition of tumor development. The considered signaling system, playing a significant role in the physiology of normal cells, often functions as a decisive factor in the survival of tumor cells, providing fine context-dependent regulation of many cellular processes associated with oncogenesis. However, despite many years of in-depth studies of the pathogenesis of diabetes mellitus and malignant tumors, the molecular mechanisms of the relationship between these pathologies are still largely unclear, and the internal heterogeneity of pathologies complicates research and interpretation of the results, leaving many questions.